Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00972790
Other study ID # 09-0041-GAP
Secondary ID
Status Completed
Phase N/A
First received September 4, 2009
Last updated February 29, 2012
Start date March 2010
Est. completion date December 2011

Study information

Verified date December 2011
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Ministry of Health & Long Term Care, Ontario
Study type Interventional

Clinical Trial Summary

The objective of this study is to demonstrate that scalp nerve blocks ("scalp freezing"), performed at the end of supratentorial brain surgery, will reduce post-operative pain, opioids side effects, and the time required for post-anaesthesia care unit (PACU)/Intensive Care Unit (ICU) and hospital discharge.


Description:

The proposed study is a randomized, placebo-controlled, triple-blinded, parallel-group clinical trial. Patients will be recruited from the neurosurgical population at St. Michael's Hospital.

The inclusion criteria are:

- Adults aged 18 years and over;

- scheduled for one of the following supratentorial craniotomy:

1. resection of a brain tumour

2. clipping of an un-ruptured cerebral aneurysm

3. excision of an artero-venous malformation (AVM), or

4. removal of an epileptic focus

- ASA physical status < IV

Intervention group: scalp nerve blocks with 20 ml of bupivacaine 0.5% + epinephrine 1:200,000 (divided among the different injection sites) at the end of surgery and before removal of the endo-tracheal tube. Control group: equal injections with 20 ml of saline + epinephrine 1:200,000 (at same time). In both study arms, post-operative rescue analgesia will be provided with hydromorphone patient-controlled analgesia (PCA).

The primary outcome of this study will be the 24h post-operative pain score as assessed by the visual analogue scale (VAS).

Important secondary outcomes will be:

- the total PCA hydromorphone consumption in the first 24 and 48 post-operative hours;

- the incidence of nausea and vomiting in the first 24 and 48 post-operative hours;

- time to reach discharge eligibility from the PACU/ICU and hospital length of stay.

Patients will be asked to rate their pain using the VAS at 30 min, 1, 2, 4, 8, 12, 18, 24, and 48 h, postoperatively by the research coordinator/bedside nurse. Pain will be also assessed at 5, 30 and 60 days postoperatively with the use of a Numeric Rating Scale (0-10).


Recruitment information / eligibility

Status Completed
Enrollment 89
Est. completion date December 2011
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults aged 18 years and over;

- patients scheduled for elective craniotomy under general anaesthesia for one of the following surgeries:

- resection of a supratentorial brain tumour,

- clipping of an un-ruptured supratentorial cerebral aneurysm,

- excision of a supratentorial arterio-venous malformation (AVM),

- removal of an epileptic focus under general anaesthetic.

- ASA physical status < IV.

Exclusion Criteria:

- history of significant coronary artery disease (NYHA class III or IV) which would contraindicate the use of epinephrine;

- presence of pain related to the intracranial pathology (e.g. tumour pain) since it could make difficult the discrimination between the tumour pain itself and the surgery related pain;

- current history of alcohol abuse or recreational drug abuse;

- active psychotic disorder;

- history of chronic pain requiring chronic opioids use (patients on opioids for > 2 weeks);

- known or suspected addiction to narcotic substances;

- presence of any acute distracting pain;

- history of migraines;

- inability to understand or incapacity to use the VAS;

- proven or suspected allergy to local anaesthetics;

- craniotomy incision extending beyond the field of the block;

- predicted need for postoperative ventilation;

- history of scalp paresthesia or scalp scarring that may preclude normal nerve anatomy;

- previous craniotomy or cranial irradiation;

- history of malignant hyperthermia, which would contraindicate the anaesthesia maintenance protocol of this study;

- pregnancy.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Procedure:
Bilateral Scalp Nerve Blocks
Scalp nerve blocks will be performed bilaterally at the end of the surgery under general anaesthesia and before removal of the head holder. Patients will receive scalp nerve blocks with a total of 20 ml of 0.5% bupivacaine + epinephrine 1:200,000 or 20 ml of saline + epinephrine 1:200,000. Solution volume is as follows: 2ml each bilaterally for supraorbital and supratrochlear nerves; 3 ml for the auriculotemporal nerves; 2 ml for the postauricular branches of the greater auricular nerves and for the greater, lesser, and third occipital nerves 3 ml of solution will be infiltrated along the superior nuchal line, approximately halfway between the occipital protuberance and the mastoid process.

Locations

Country Name City State
Canada St. Michael's Hospital Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
St. Michael's Hospital, Toronto The Physicians' Services Incorporated Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome will be the 24h post-operative VAS score among adults undergoing supratentorial craniotomy. 24 hours No
Secondary 48h post-operative pooled VAS score 48 hours No
Secondary the total PCA hydromorphone consumption in the first at 24 and 48 post-operative hours 24 and 48 hours No
Secondary total hydromorphone demands and delivered doses in the first 24 and 48 post-operative hours 24 and 48 hours No
Secondary the incidence of nausea and vomiting in the first 24 and 48 post-operative hours 24 and 48 hours No
Secondary the time for patients to reach discharge eligibility from the PACU/ICU Discharge time and date from PACU/ICU No
Secondary the time for patients to reach discharge eligibility from hospital Discharge time and date from hospital No
Secondary presence of long term pain as measured with the Numeric Rating Scale (NRS) at days 5, 30 and 60 postoperatively 5, 30 and 60 days No
Secondary Karnofsky Performance Scale Index and modified pain treatment satisfaction scale (PTSS) at day 5 day 5 No
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy N/A
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A